{"denoms":[{"counts":[{"groupId":"BG000","value":"261"},{"groupId":"BG001","value":"131"},{"groupId":"BG002","value":"392"}],"units":"Participants"}],"groups":[{"description":"Participants received lenvatinib 24 mg, hard capsule, orally, once daily, until documentation of disease progression (confirmed by IIR), development of unacceptable toxicity, or withdrawal of consent.","id":"BG000","title":"Randomization Phase: Lenvatinib 24 mg"},{"description":"Participants received matching-placebo, hard capsule, orally, once daily until documentation of disease progression (confirmed by IIR), development of unacceptable toxicity, or withdrawal of consent.","id":"BG001","title":"Randomization Phase: Placebo"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.57","value":"62.1"},{"groupId":"BG001","spread":"10.09","value":"61.5"},{"groupId":"BG002","spread":"10.40","value":"61.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"GEOMETRIC_MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"136"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"192"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"125"},{"groupId":"BG001","value":"75"},{"groupId":"BG002","value":"200"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}